Clay Siegall, Seagen CEO (L) and Sunao Manabe, Daiichi Sankyo CEO
April 21, 2022 12:27 PM EDTUpdated April 25, 06:52 AM
Manufacturing

Seagen to build man­u­fac­tur­ing site from ground up near Wash­ing­ton home

Josh Sullivan

As Seagen comes off a huge win in court that land­ed it near­ly $42 mil­lion in pay­ments for patent in­fringe­ment, it’s mak­ing plans to build …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times